MyAverix Finance
F · Healthcare
GENMAB AS SP.ADR/1/10DK 1 (GE91)
Biotechnology
GENMAB AS SP.ADR/1/10DK 1 (GE91) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $13.75B, P/E ratio is 16.84, net margin is 25.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for GE91
GENMAB AS SP.ADR/1/10DK 1 (GE91) — FAQ
What is GENMAB AS SP.ADR/1/10DK 1's market cap?
GENMAB AS SP.ADR/1/10DK 1 (GE91) has a reported market cap of $13.75B (data as of 2026-03-29).
What is GE91's P/E ratio?
The price-to-earnings (P/E) ratio for GENMAB AS SP.ADR/1/10DK 1 (GE91) is 16.84 (data as of 2026-03-29).
Does GENMAB AS SP.ADR/1/10DK 1 pay a dividend?
Dividend yield is not available in the current snapshot for GENMAB AS SP.ADR/1/10DK 1 (GE91). Check the MyAverix Finance app for the latest dividend data.
What sector is GENMAB AS SP.ADR/1/10DK 1 in?
GENMAB AS SP.ADR/1/10DK 1 (GE91) is classified in the Healthcare sector (Biotechnology industry).
What exchange is GE91 listed on?
GE91 is listed on F.
What is GENMAB AS SP.ADR/1/10DK 1's net margin?
GENMAB AS SP.ADR/1/10DK 1 (GE91) reports a net margin of 25.9% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.